ADx will attend AD/PD 2024

ADx is excited to attend AD/PD 2024 this year in Lisbon, Portugal.

Come and meet us for exciting new data on our novel prototype assays for the detection of GFAP and pS129 alpha-synuclein as well as the evaluation of associations of ADx’ synaptic biomarkers with synaptic/MRI imaging and cognitive trajectories in patients with AD, TBI and older non-demented individuals.

For a handy overview of posters and presentations from ADx and our collaborators, follow the link below.